ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
55.10
-0.59 (-1.06%)
Nov 20, 2024, 4:00 PM EST - Market closed
ANI Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for ANI Pharmaceuticals stock have an average target of 76.8, with a low estimate of 62 and a high estimate of 94. The average target predicts an increase of 39.38% from the current stock price of 55.10.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ANIP stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 2 | 3 | 3 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $94 | Strong Buy | Reiterates | $94 | +70.60% | Nov 11, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $60 → $62 | Hold | Maintains | $60 → $62 | +12.52% | Oct 22, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $68 | Buy | Initiates | $68 | +23.41% | Oct 11, 2024 |
| Raymond James | Raymond James | Buy Maintains $81 → $83 | Buy | Maintains | $81 → $83 | +50.64% | Sep 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $94 | Strong Buy | Reiterates | $94 | +70.60% | Sep 17, 2024 |
Financial Forecast
Revenue This Year
602.12M
from 486.82M
Increased by 23.69%
Revenue Next Year
716.20M
from 602.12M
Increased by 18.95%
EPS This Year
4.82
from 0.85
Increased by 465.93%
EPS Next Year
5.65
from 4.82
Increased by 17.36%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 628.6M | 751.1M | 803.7M | ||
| Avg | 602.1M | 716.2M | 752.3M | ||
| Low | 569.3M | 658.4M | 676.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 29.1% | 24.7% | 12.2% | ||
| Avg | 23.7% | 18.9% | 5.0% | ||
| Low | 16.9% | 9.3% | -5.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 5.07 | 6.41 | 7.27 | ||
| Avg | 4.82 | 5.65 | 6.42 | ||
| Low | 4.41 | 5.01 | 5.24 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 495.6% | 32.9% | 28.5% | ||
| Avg | 465.9% | 17.4% | 13.5% | ||
| Low | 417.9% | 3.9% | -7.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.